Quercetin reduces susceptibility to influenza infection following stressful exercise.
Exercise stress is associated with increased risk for upper respiratory tract infection. We have shown that exercise stress can increase susceptibility to infection. Quercetin, a flavonoid present in a wide variety of fruits and vegetables, has been reported to inhibit infectivity and replication of a broad spectrum of viruses and may offset the increase in susceptibility to infection associated with stressful exercise. This study examined the effects of quercetin feedings on susceptibility to the influenza virus A/Puerto Rico/8/34 (H1N1) following stressful exercise. Mice were randomly assigned to one of four treatment groups: exercise-placebo, exercise-quercetin, control-placebo, or control-quercetin. Exercise consisted of a run to fatigue (approximately 140 min) on a treadmill for 3 consecutive days. Quercetin (12.5 mg/kg) was administered via gavage for 7 days before viral challenge. At 30 min after the last bout of exercise or rest, mice (n=23-30) were intranasally inoculated with a standardized dose of influenza virus (0.04 hemagglutinating units). Mice were monitored daily for morbidity (time to sickness), symptom severity, and mortality (time to death) for 21 days. Exercise stress was associated with an increased susceptibility to infection [morbidity, mortality, and symptom severity on days 5-7 (P<0.05)]; quercetin offset the increase in susceptibility to infection [morbidity, mortality, and symptom severity on days 5-7 (P<0.05)] that was associated with stressful exercise. These data suggest that short-term quercetin feedings may prove to be an effective strategy to lessen the impact of stressful exercise on susceptibility to respiratory infection.
Davis
J M
JM
University of South Carolina, Department of Exercise Science, PHRC #301, 921 Assembly St., Columbia, SC 29208, USA. markd@gwm.sc.edu
Murphy
E A
EA
McClellan
J L
JL
Carmichael
M D
MD
Gangemi
J D
JD
D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D053118:Influenza A Virus, H1N1 Subtype / Q000472:pathogenicity; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009976:Orthomyxoviridae Infections / Q000503:physiopathology / Q000517:prevention & control* / Q000821:virology; D005082:Physical Exertion; D011794:Quercetin / Q000494:pharmacology*; D012141:Respiratory Tract Infections / Q000503:physiopathology / Q000517:prevention & control* / Q000821:virology; D012720:Severity of Illness Index; D013312:Stress, Physiological / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D000998:Antiviral Agents; D011794:Quercetin